| STJ505803
| Somatostatin Receptor 2 Positive Control for STJ506058 peptide (STJ505803)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505784
| STK3/MST-2 Blocking Peptide for STJ506031 peptide (STJ505784)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ506343
| NeuroD1 Positive Control for STJ506340 peptide (STJ506343)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505817
| SARS-CoV-2 ORF6 Positive Control for STJ506078 peptide (STJ505817)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ506380
| MBOAT1 Positive Control for STJ507773 peptide (STJ506380)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505651
| RIOK1 Blocking Peptide for STJ502788 peptide (STJ505651)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505726
| SRPK1 Blocking Peptide for STJ505943 peptide (STJ505726)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505632
| IRF8 Blocking Peptide for STJ501501 peptide (STJ505632)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505719
| P70 S6 Kinase beta Positive Control for STJ505931 peptide (STJ505719)
| 5 Applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505774
| MHC Class II Blocking Peptide for STJ506016 peptide (STJ505774)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505771
| ZAP70 Positive Control for STJ506009 peptide (STJ505771)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505832
| PDE11A Blocking Peptide peptide (Phospho) (S163) (STJ505832)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505838
| CGRP Blocking Peptide for STJ506112 peptide (STJ505838)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505851
| TREML1 Blocking Peptide for STJ506131 peptide (STJ505851)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505655
| Twist Blocking Peptide peptide (STJ505655)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505681
| DDDDK Blocking Peptide for STJ501050 peptide (STJ505681)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505737
| PP2A-gamma Positive Control for STJ505958 peptide (STJ505737)
| 5 Applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505657
| Elf4/MEF Blocking Peptide for STJ500869 peptide (STJ505657)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505813
| SARS-CoV-2 envelope protein Positive Control for STJ506072 peptide (STJ505813)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ506441
| ALCAM Blocking Peptide for STJ506439 peptide (STJ506441)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505843
| Profilin Positive Control for STJ506120 peptide (STJ505843)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505783
| Serine/threonine-protein kinase 4/MST-1 Positive Control for STJ506026 peptide (STJ505783)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505686
| TMC1 Positive Control for STJ503319 peptide (STJ505686)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505741
| Bruchpilot Positive Control for STJ505966 peptide (STJ505741)
| 5 Applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ506301
| SARS CoV-2 Spike Glycoprotein Brazil variant Blocking Peptide for STJ506298 peptide (Brazil variant) (STJ506301)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505660
| Estrogen Related Receptor gamma Positive Control peptide (STJ505660)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505666
| Brk Positive Control for STJ502711 peptide (STJ505666)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ507778
| ADCY2 Positive Control for STJ502054 peptide (STJ507778)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ507760
| GCDH/GCD Positive Control for STJ507756 peptide (STJ507760)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ506432
| ADCY2 Positive Control for STJ502054 peptide (STJ506432)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505885
| SARS-CoV-2 Envelope Recombinant Protein peptide (STJ505885)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505616
| Aurora B Blocking Peptide peptide (STJ505616)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505811
| SARS-CoV-2 ORF3a Positive Control for STJ506070 peptide (STJ505811)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505890
| TESK2 Positive Control for STJ506192 peptide (STJ505890)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505753
| OTOP1 Positive Control for STJ505980 peptide (STJ505753)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ506337
| Skn1 Blocking Peptide for STJ506334 peptide (STJ506337)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505634
| CC2D1A Blocking Peptide for STJ500381 peptide (STJ505634)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505830
| MLKL Blocking Peptide peptide (Phospho) (STJ505830)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ506377
| TREM2 Blocking Peptide for STJ506376 peptide (STJ506377)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505800
| EHMT1/GLP1 Blocking Peptide for STJ506053 peptide (STJ505800)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505809
| SARS-CoV-2 surface glycoprotein Positive Control for STJ506067 peptide (STJ505809)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505650
| FLT3/CD135 Positive Control peptide (STJ505650)
| 5 Applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ506247
| Dnmt1 Positive Control for STJ506245 peptide (STJ506247)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505751
| CRALBP Positive Control for STJ505977 peptide (STJ505751)
| 5 Applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505799
| PI3R6 Positive Control for STJ506052 peptide (STJ505799)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505743
| Bruchpilot Positive Control peptide (Phospho) (STJ505743)
| 5 Applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505645
| KMT6/EZH2 Blocking Peptide peptide (STJ505645)
| 250 µg
| St Johns Labora
| Immunodepletion/Immunocompetition
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505852
| TREML1 Positive Control for STJ506133 peptide (STJ505852)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ506392
| PLK4 Positive Control peptide (Phospho) (STJ506392)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|
| STJ505815
| SARS-CoV-2 membrane glycoprotein Positive Control for STJ506076 peptide (STJ505815)
| 5 applications
| St Johns Labora
| WB
|
|
|
| Solicitar Precio
| Solicitar
|